Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Zoledronate for metastatic bone disease and pain: a meta-analysis of randomized clinical trials.

Zhu M, Liang R, Pan LH, Huang B, Qian W, Zhong JH, Zheng WW, Li CL.

Pain Med. 2013 Feb;14(2):257-64. doi: 10.1111/pme.12016. Epub 2012 Dec 28.

PMID:
23279447
[PubMed - indexed for MEDLINE]
2.

Bisphosphonates in multiple myeloma: a network meta-analysis.

Mhaskar R, Redzepovic J, Wheatley K, Clark OA, Miladinovic B, Glasmacher A, Kumar A, Djulbegovic B.

Cochrane Database Syst Rev. 2012 May 16;5:CD003188. doi: 10.1002/14651858.CD003188.pub3. Review.

PMID:
22592688
[PubMed - indexed for MEDLINE]
3.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
[PubMed - indexed for MEDLINE]
4.

Bisphosphonates and other bone agents for breast cancer.

Wong MH, Stockler MR, Pavlakis N.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD003474. doi: 10.1002/14651858.CD003474.pub3. Review.

PMID:
22336790
[PubMed - indexed for MEDLINE]
5.

Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.

Machado M, Cruz LS, Tannus G, Fonseca M.

Clin Ther. 2009 May;31(5):962-79. doi: 10.1016/j.clinthera.2009.05.009. Review.

PMID:
19539097
[PubMed - indexed for MEDLINE]
6.

Bisphosphonates for breast cancer.

Pavlakis N, Stockler M.

Cochrane Database Syst Rev. 2002;(1):CD003474. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003474.

PMID:
11869664
[PubMed - indexed for MEDLINE]
7.

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.

Tunn UW, Stenzl A, Schultze-Seemann W, Strauss A, Kindler M, Miller K, Wirth MP, Zantl N, Schulze M, May C, Ruebel A, Birkholz K, Gruenwald V.

Can J Urol. 2012 Jun;19(3):6261-7.

PMID:
22704310
[PubMed - indexed for MEDLINE]
8.

Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.

Saad F, Eastham J.

Urology. 2010 Nov;76(5):1175-81. doi: 10.1016/j.urology.2010.05.026.

PMID:
21056263
[PubMed - indexed for MEDLINE]
9.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
[PubMed - indexed for MEDLINE]
10.

Bisphosphonates for advanced prostate cancer.

Yuen KK, Shelley M, Sze WM, Wilt T, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006250. Review.

PMID:
17054286
[PubMed - indexed for MEDLINE]
11.

Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis.

Lopez-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME.

Support Care Cancer. 2012 Nov;20(11):2985-98. doi: 10.1007/s00520-012-1563-z. Epub 2012 Sep 7. Review.

PMID:
22956190
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.

Ding X, Fan Y, Ma F, Li Q, Wang J, Zhang P, Yuan P, Xu B.

Breast. 2012 Aug;21(4):544-9. doi: 10.1016/j.breast.2012.04.008. Epub 2012 May 22.

PMID:
22627092
[PubMed - indexed for MEDLINE]
13.

Bisphosphonates for osteoporosis in primary biliary cirrhosis.

Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009144. doi: 10.1002/14651858.CD009144.pub2. Review.

PMID:
22161446
[PubMed - indexed for MEDLINE]
14.

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.

Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J.

Cancer. 2004 Jun 15;100(12):2613-21.

PMID:
15197804
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer.

Saad F.

Clin Prostate Cancer. 2005 Jun;4(1):31-7.

PMID:
15992459
[PubMed - indexed for MEDLINE]
16.

A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer.

Zaghloul MS, Boutrus R, El-Hossieny H, Kader YA, El-Attar I, Nazmy M.

Int J Clin Oncol. 2010 Aug;15(4):382-9. doi: 10.1007/s10147-010-0074-5. Epub 2010 Apr 1.

PMID:
20354750
[PubMed - indexed for MEDLINE]
17.

Efficacy and safety of denosumab versus zoledronic acid in patients with bone metastases: a systematic review and meta-analysis.

Sun L, Yu S.

Am J Clin Oncol. 2013 Aug;36(4):399-403. doi: 10.1097/COC.0b013e31824be20e. Review.

PMID:
22772430
[PubMed - indexed for MEDLINE]
18.

Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis.

Peddi P, Lopez-Olivo MA, Pratt GF, Suarez-Almazor ME.

Cancer Treat Rev. 2013 Feb;39(1):97-104. doi: 10.1016/j.ctrv.2012.07.002. Epub 2012 Aug 13. Review.

PMID:
22898302
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.

Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE.

Breast Cancer Res Treat. 2010 Oct;123(3):767-79. doi: 10.1007/s10549-010-0981-1. Epub 2010 Jun 24.

PMID:
20574672
[PubMed - indexed for MEDLINE]
20.

Radioisotopes for metastatic bone pain.

Roqué M, Martinez MJ, Alonso P, Català E, Garcia JL, Ferrandiz M.

Cochrane Database Syst Rev. 2003;(4):CD003347. Review. Update in: Cochrane Database Syst Rev. 2011;(7):CD003347.

PMID:
14583970
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk